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LEISHMANIA MEXICANA AM AZONENSIS  ISOLATED FROM A PATIENT 
WITH FATAL MUCOSAL LEISHMANIASIS
There have been two previous references in the 
literature to mexicana type organisms isolated from 
patients with mucosal leishmanial granuloma1 We 
have recently identified a stock recovered from a 
patient with a severe mucosal lesion as Leishm ania  
mexicana amazonensis using monoclonal antibodies 
and two techniques immunofluorescence (IFA ) and 
radio immune binding assay2.
The patient (Reg. n? 157049) was a 20 year old 
office clerk who had lived ali his life in the town of 
J acobina. Bahia. At eleven years of age a skin ulcer. which 
left a typical scar on his right ankle. had healed after 
glucantime therapy. The nasal lesion had developed 
one year later and during the last eight years he had 
received various schemes of glucantime treatment 
(dose not recalled) and Amphotericin B to a total of 5 
grams in a hospital in Salvador. Bahia.
As shown in the figure he had a severe des- 
tructive lesion of the nose with septal loss. Granulo- 
matous inflammation involved the mouth, upper lip, 
pharynx and larynx. His voice was hoarse and weak. 
The lower lip and the tongue were spared. The case
was remarkable for the degree of erythema of the nose 
and upper lip. Secondary bacterial infection with 
purulent secretion was present.
Amastigotes were easily visualised in smears 
and H&E sections from the biopsies of mucosal 
granuloma and triturated material yielded the isolate 
on hamster inoculation. Although the IFA  titre was 
320, the leishmanin skin test was repeatedly negative 
as were skin tests using DNCB, tuberculin and 
paracoccidiodin. He was treated with 10 mg Sbv/Kilo- 
gram/day of Pentostam for 30 days with considerable 
improvement and discharged to be followed up in out 
patients. Unfortunately he defaulted but retumed 3 
months later with a severely inflammed facial area and 
evidence of malnutrition. The IFA  titre was the same 
at this time. Amphotericin B treatment was initiated but 
he developed bronchopneumonia, septicemia and died 
within a few days.
This patient is the only one of 20 with characte- 
rised mucosal isolates in our studies who had L. 
mexicana amazonensis; the rest had Leishmania 
braziliensis braziliensis. It appears that L. m.
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amazonensis can metastasise to the mucosa after an 
initial skin lesion. However our patient had evidence of 
suppressed cell mediated immunity on skin testing 
although he was producing antibody. A negative 
leishmanin skin test is a bad prognostic sign as this 
patient well illustrates3. Associated malnutrition 
could explain the impaired cellular immune responses 
and the unusual behavior ofL. m. amazonensis in this 
patient. W alton et a lA  explained another mucosal 
lesion caused by L. mexicana  on the grounds that the 
patient had received prior radiation therapy for 
neoplastic disease.
Nevertheless it was disappointing that he died. 
Today with better knowledge of how to handle 
maximal antimonial therapy^ we would not use such a 
low continuous dose for only 30 days. W e have cured 
recalcitrant disease with as long as 85 days continuous 
therapy at double the dose this patient received with a 
favourable outcome^. The fact that he responded well 
to 10 mg Sbv/kilo/day for 30 days indicates that if we 
had adopted such a regimen he might well be alive 
today.
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